Browsing Bergen Open Research Archive by Author "Førde, Jan-Lukas"
Now showing items 1-6 of 6
-
Graphene-based phenformin carriers for cancer cell treatment: a comparative study between oxidized and pegylated pristine graphene in human cells and zebrafish
Alhourani, Abdelnour; Førde, Jan-Lukas; Nasrollahzadeh, Mojdeh; Eichacker, Lutz Andreas; Herfindal, Lars; Hagland, Hanne Røland (Journal article; Peer reviewed, 2022)Graphene is an attractive choice for the development of an effective drug carrier in cancer treatment due to its high adsorption area and pH-responsive drug affinity. In combination with the highly potent metabolic drug ... -
Improved pH-Responsive Release of Phenformin from Low-Defect Graphene Compared to Graphene Oxide
Alhourani, Abdelnour; Førde, Jan-Lukas; Eichacker, Lutz Andreas; Herfindal, Lars; Hagland, Hanne Røland (Journal article; Peer reviewed, 2021)Graphene-based drug carriers provide a promising addition to current cancer drug delivery options. Increased accessibility of high-quality graphene made by plasma-enhanced chemical vapor deposition (PE-CVD) makes it an ... -
A new software tool for computer assisted in vivo high-content analysis of transplanted fluorescent cells in intact zebrafish larvae
Førde, Jan-Lukas; Reiten, Ingeborg Nerbø; Fladmark, Kari Espolin; Kittang, Astrid Marta Olsnes; Herfindal, Lars (Journal article; Peer reviewed, 2022)Acute myeloid leukemia and myelodysplastic syndromes are cancers of the bone marrow with poor prognosis in frail and older patients. To investigate cancer pathophysiology and therapies, confocal imaging of fluorescent ... -
Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro
Førde, Jan-Lukas; Herfindal, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind; Mollnes, Tom Eirik; Skrede, Silje (Journal article; Peer reviewed, 2023)The clinical and adverse effects of the therapeutic monoclonal antibodies (mAb) ocrelizumab, ofatumumab and rituximab in multiple sclerosis (MS) are presently subject to extensive study. While the two former are approved ... -
Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation
Gundersen, Edvin Tang; Førde, Jan-Lukas; Tislevoll, Benedicte Sjo; Leitch, Calum; Barratt, Gillian; Gjertsen, Bjørn Tore; Herfindal, Lars (Journal article; Peer reviewed, 2022)Treatment of acute myeloid leukaemia (AML) relies on decades-old drugs, and while recent years have seen some breakthroughs, AML is still characterised by poor prognosis and survival rate. Drug repurposing can expedite the ... -
The Zebrafish Larva as a Model System for Myeloid Malignancies
Førde, Jan-Lukas (Doctoral thesis, 2024-02-23)Myeloid kreft er ein ukontrollert deling av dei myeloide stamcellene som finst i beinmergen. Døme på myeloid kreft er akutt myeloid leukemi (AML) og myelodysplastisk syndrom. Desse kreftformane er vanlegast hjå eldre ...